The science behind biosimilars is an initiative carried out by BioSim, in collaboration with its partners mAbxience, Sandoz and Fresenius Kabi, to promote knowledge about biosimilar medicines and all the opportunities they offer. From the hands of different professionals from scientific-medical areas, they will tell us what the appearance and permanence of biosimilars in the therapeutic arsenal means and their contribution to the administration, health professionals and patients.